索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]朱政斌,张瑞岩.经皮主动脉瓣置换临床进展及未来展望[J].国际心血管病杂志,2016,06:326-330.
点击复制

经皮主动脉瓣置换临床进展及未来展望(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2016年06期
页码:
326-330
栏目:
综述
出版日期:
2016-11-20

文章信息/Info

Title:
-
作者:
朱政斌; 张瑞岩
200025 上海交通大学医学院附属瑞金医院心内科
Author(s):
-
关键词:
经皮主动脉瓣置入术; 主动脉瓣狭窄; 主动脉瓣置换手术
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2016.06.002
文献标识码:
-
摘要:
经皮主动脉瓣置入术(transcatheteraorticvalveimplantation,TAVI)自最初的临床试用至今已十几年。近年来的多项研究显示,TAVI术不仅在高危重度主动脉瓣狭窄患者中逐渐取代甚至超越传统外科主动脉瓣置换术(surgicalaorticvalvereplacement,SAVR),而且在中低危患者中也有较好的应用前景。已有多项研究比较了球囊扩张型和自膨胀型TAVI瓣膜的临床疗效,机械扩张型瓣膜也在近期的临床应用中获得好评。该文主要介绍TAVI的临床应用历程和器械的研发进展。
Abstract:
-

参考文献/References

[1] Cribier A, Eltchaninoff H, Tron C. First human transcatheter implantation of an aortic valve prosthesis in a case of severe calcific aortic stenosis[J].Ann Cardiol Angeiol(Paris), 2003, 52(3):173-175.
[2] Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience[J]. Circulation, 2006, 114(6):591-596.
[3] Walther T, Chu MW, Mohr FW. Transcatheter aortic valve implantation: time to expand?[J]. Curr Opin Cardiol, 2008, 23(2):111-116.
[4] Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery[J]. N Engl J Med, 2010, 363(17):1597-1607.
[5] Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients[J]. N Engl J Med, 2011, 364(23):2187-2198.
[6] Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis[J]. N Engl J Med, 2014, 370(19):1790-1798.
[7] Deeb GM, Reardon MJ, Chetcuti S, et al. 3-year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement[J]. J Am Coll Cardiol, 2016, 67(22):2565-2574.
[8] Reardon MJ, Kleiman NS, Adams DH, et al. Outcomes in the randomized corevalve US pivotal high-risk trial in patients with a society of thoracic surgeons risk score of 7% or less[J]. JAMA Cardiol, 2016.
[9] Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients[J]. N Engl J Med, 2016, 374(17):1609-1620.
[10] Iturra SA, Suri RM, Greason KL, et al. Outcomes of surgical aortic valve replacement in moderate risk patients: implications for determination of equipoise in the transcatheter era[J]. J Thorac Cardiovasc Surg, 2014, 147(1):127-132.
[11] Jabbour RJ, Pagnesi M, Kawamoto H, et al. Transcatheter aortic valve implantation in intermediate- and low-risk populations: an inevitable progression[J] Int J Cardiol, 2016, 210:35-37.
[12] Castrodeza J, Amat-Santos IJ, Blanco M, et al. Propensity score matched comparison of transcatheter aortic valve implantation versus conventional surgery in intermediate and low risk aortic stenosis patients: a hint of real-world[J]. Cardiol J, 2016.
[13] Phan K, Zhao DF, Wang N, et al. Transcatheter valve-in-valve implantation versus reoperative conventional aortic valve replacement: a systematic review[J]. J Thorac Dis,2016, 8(1):E83-93.
[14] Ejiofor JI, Yammine M, Harloff MT, et al. Reoperative surgical aortic valve replacement versus transcatheter valve-in-valve replacement for degenerated bioprosthetic aortic valves[J]. Ann Thorac Surg, 2016, 102(5): 1452-1458.
[15] Conte JV, Gleason TG, Resar JR, et al. Transcatheter or surgical aortic valve replacement in patients with prior coronary artery bypass grafting[J]. Ann Thorac Surg, 2016, 101(1):72-79.
[16] Ludman PF, Moat N, de Belder MA, et al. Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK transcatheter aortic valve implantation(TAVI)registry, 2007 to 2012[J]. Circulation, 2015, 131(13):1181-1190.
[17] John MLasala, Jason H Rogers. Interventional procedure for adult structural heart disease[M].Elsevier, 2014: 73-89.
[18] Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial[J]. JAMA, 2014, 311(15):1503-1514.
[19] Abdel-Wahab M, Neumann FJ, Mehilli J, et al. 1-year outcomes after transcatheter aortic valve replacement with balloon-expandable versus self-expandable valves: results from the CHOICE randomized clinical trial[J]. J Am Coll Cardiol, 2015, 66(7):791-800.
[20] Walther T, Hamm CW, Schuler G, et al. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry[J]. J Am Coll Cardiol, 2015, 65(20):2173-2180.
[21] Panchal HB, Barry N, Bhatheja S, et al. Mortality and major adverse cardiovascular events after transcatheter aortic valve replacement using Edwards valve versus CoreValve: a meta-analysis[J]. Cardiovasc Revasc Med, 2016, 17(1):24-33.
[22] Bhatheja S, Panchal HB, Barry N, et al. Valvular performance and aortic regurgitation following transcatheter aortic valve replacement using Edwards valve versus CoreValve for severe aortic stenosis: a meta-analysis[J]. Cardiovasc Revasc Med, 2016, 17(4):248-255.
[23] Agarwal S, Parashar A, Kumbhani DJ, et al. Comparative meta-analysis of balloon-expandable and self-expandable valves for transcatheter aortic valve replacement[J]. Int J Cardiol, 2015,197:87-97.
[24] Meredith IT, Walters DL, Dumonteil N, et al. 1-year outcomes with the fully repositionable and retrievable lotus transcatheter aortic replacement valve in 120 high-risk surgical patients with severe aortic stenosis: results of the REPRISE Ⅱ Study[J]. JACC Cardiovasc Interv, 2016, 9(4):376-384.
[25] Biancari F, Rosato S, D'Errigo P, et al. Immediate and intermediate outcome after transapical versus transfemoral transcatheter aortic valve replacement[J]. Am J Cardiol, 2016, 117(2):245-251.
[26] Blackstone EH, Suri RM, Rajeswaran J, et al. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves(PARTNER)-Ⅰ trial substudy[J]. Circulation,2015, 131(22):1989-2000.
[27] Gualano SK, Kumbhani DJ. At the heart of matters: the role of the heart team in transcatheter aortic valve replacement[J]. Trends Cardiovasc Med, 2015, 25(2):162-163.

备注/Memo

备注/Memo:
通信作者:张瑞岩,Email:zhangruiyan@263.net
更新日期/Last Update: 2016-11-20